Webcast CME

How to Obtain AMA PRA Category 1 Credit

  1. Complete the Activity.
  2. Complete the CME posttest (each question must be answered correctly).
  3. Log into your myCME account.
  4. Complete the credit and evaluation form.
  5. Print your personalized CME certificate.
  6. Credit can only be claimed once for this activity.

Technical Requirements

Advances in the
Management of Chronic Gout

Print this Content

Release Date:  August 24, 2016
Renewal Date:  August 24, 2017
Expiration Date:  August 24, 2018

Estimated Time of Completion: 1 hour 15 minutes

Description

The goal of this educational activity is to broaden the knowledge base of participants and to enhance their competence in management strategies for patients with chronic gout and thus improve the care of this patient population.

Learning Objectives

  1. Discuss the role of MSU crystals in the activation and dysregulation of inflammasome function in the pathogenesis of gout.
  2. Review the criteria for confirming the diagnosis of gout.
  3. Summarize the current guidelines for the management of chronic gout.
  4. Evaluate the therapeutic targets in a treat to target approach of gout.

Target Audience

This activity is directed to physicians, internists, general practitioners, rheumatologists, and other medical professionals who manage patients with gout.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of  1.25 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Activity Director and Faculty

Activity Director

Leonard Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Theodore F. Classen DO Chair of Osteopathic Research and Education
Cleveland Clinic
Cleveland, OH

Faculty

Peter E. Lipsky, MD
CEO, AMPEL BioSolutions, LLC
Charlottesville, VA

Brian Mandell, MD, PhD
Chairman, Department of Medicine, Education Institute
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Cleveland Clinic
Cleveland, OH

Robert Terkeltaub, MD
Professor of Medicine, UCSD
Division of Rheumatology, Allergy and Immunology
Rheumatology Training Program Director
San Diego VA Medical Center
San Diego, CA

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated they may have a relationship, which in the context of their presentations, could be perceived as a potential conflict of interest:

Peter Lipsky, MD
  Horizon Pharma Consulting
 
Brian Mandell, MD, PhD
  Horizon Pharma Consulting
 
Robert Terkeltaub, MD
  Ardea; AstraZeneca Pharmaceuticals Consulting, Membership on advisory committee or review panels
  CymaBay Therapeutics Inc.; Horizon Pharma; ProteoThera, Inc.; Relburn-Metabolomics Inc.; Revive; Selecta Biosciences Inc.; SOBI Consulting
  Aequus Pharmaceuticals Board Membership, Consulting

The following faculty has indicated that he has no relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:

Leonard Calabrese, DO

All other planners, CME staff, and content reviewers have no relevant financial relationships to disclose.

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges an educational grant for support of this activity from:


Horizon Pharma, Inc.

This CME activity was produced by the Cleveland Clinic Center for Continuing Education,
Cleveland Clinic's R.J. Fasenmyer Center for Clinical Immunology, and Dinora, Inc.